Organization
Henry M. Jackson Foundation for the Advancement of Military Medicine
14 clinical trials
Clinical trial
A Randomized Controlled Trial Evaluating Single-dose Rifaximin Versus Azithromycin With Loperamide Adjunct for Treatment of Acute Watery DiarrheaStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Treatment of Acute Post-Traumatic Headache With Erenumab 140 mg, Military Service Members and Civilians With Mild TBI: A Randomized, Double Blind, Placebo Controlled, Multicenter 12-week Duration Study Followed by a 4-week Open-Label Safety ExtensionStatus: Recruiting, Estimated PCD: 2026-05-19
Clinical trial
Safety and Efficacy of Broadly Neutralizing Antibodies Followed by Innate Immune Stimulation and Therapeutic Vaccination for the Induction of HIV RemissionStatus: Withdrawn, Estimated PCD: 2025-07-01
Clinical trial
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoDStatus: Active (not recruiting), Estimated PCD: 2022-07-07
Clinical trial
Ketamine for Sedation in Severe Traumatic Brain InjuryStatus: Not yet recruiting, Estimated PCD: 2027-01-01
Clinical trial
Master Protocol for Early Treatment and Post-Exposure Prophylaxis of COVID-19 Adaptive Platform Trial PROTECT-APT 1Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Randomized, Multi-Center Trial to Evaluate the Safety & Immunogenicity of Staphylococcus Aureus Toxoids, rAT and rLukS-PV, in Healthy VolunteersStatus: Completed, Estimated PCD: 2011-03-01
Clinical trial
A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg Daily or 550 mg Twice Daily) for Chemoprophylaxis Against Travelers' Diarrhea (TD) Among Active Duty Deployed U.S. and British Military PersonnelStatus: Completed, Estimated PCD: 2019-07-01
Clinical trial
Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military TraineesStatus: Completed, Estimated PCD: 2012-01-01
Clinical trial
Self-Administered Nasal Influenza Vaccine: Immunogenicity and Feasibility of Group AdministrationStatus: Completed, Estimated PCD: 2013-10-01
Clinical trial
Screening for Latent Tuberculosis Infection (LTBI) in US Army RecruitsStatus: Completed, Estimated PCD: 2009-06-01
Clinical trial
Prospective Study on the Incidence, Predictors, and Characteristics of Methicillin-Resistant Staphylococcus Aureus Infections and a Randomized, Double-Blind Study on Decolonization Procedures for Prevention of MRSA Infections Among HIV-Infected PersonsStatus: Completed, Estimated PCD: 2017-05-01
Clinical trial
Phase I, Proof of Concept, Open-Label, Randomized Clinical Trial to Evaluate the Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and YouthStatus: Active (not recruiting), Estimated PCD: 2023-10-16
Clinical trial
Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV): Safety and Efficacy of Broadly Neutralizing Antibodies Combined With Therapeutic Vaccination for the Induction of HIV RemissionStatus: Not yet recruiting, Estimated PCD: 2027-08-01